این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
International Journal of Hematology-Oncology and Stem Cell Research، جلد ۱۳، شماره ۲، صفحات ۱۰۲-۱۰۷
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Liposomal Vincristine as a Bridge Therapy Prior to CAR-T Therapy in Relapsed and Refractory Diffuse Large B-Cell Lymphoma?
چکیده انگلیسی مقاله We report a case of a 76-year-old male with a history of relapsed and refractory diffuse large B-cell lymphoma (DLBCL).Our patient was initially treated with front line chemotherapy along with central nervous system (CNS) prophylaxis with complete response. He subsequently relapsed, was sensitive to second-line chemotherapy, and underwent autologous stem cell transplantation achieving a complete remission. Only a few months after transplant, the patient suffered his second relapse and was deemed a candidate for Chimeric Antigen Receptor T-Cell Therapy (CAR-T). Given his aggressive disease, combined with the time needed to generate CAR-T cells, a multidisciplinary team recommended to treat our patient with liposomal vincristine in combination with rituximab as a bridge therapy. Durable responses have been seen using liposomal vincristine based on results from a recent phase II trial in heavily pretreated patients with DLBCL1. This therapy was effective in stabilizing and reducing active disease in our patient. This case looks to illustrate the use of liposomal vincristine in combination with immunotherapy in a novel setting bridging highly selected patients with active and refractory lymphoma prior to CAR-T. Moreover, we expanded an additional therapeutic point, highlighting the importance of optimal disease control prior to CAR-T cell harvesting, as recent literature has shown that residual malignant cells in the pheresis product may be inadvertently be transfected with the CAR gene, resulting in resistance and further relapse2.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله | Juskaran Chadha
Department of Hematology & Medical Oncology, Lenox Hill Hospital Northwell Health, New York, NY


| Shafinaz Hussein
Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA


| Yougen Zhan
Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA


| Jonah Shulman
Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA


| Joshua Brody
Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA


| Lynn Ratner
Department of Hematology & Medical Oncology, Lenox Hill Hospital Northwell Health, New York, NY


| Amir Steinberg
Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA
نشانی اینترنتی http://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1070
فایل مقاله اشکال در دسترسی به فایل - ./files/site1/rds_journals/78/article-78-1970087.pdf
کد مقاله (doi)
زبان مقاله منتشر شده
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات